Embracing Risk Assessment: Using the Failure Mode and Effect Analysis (FMEA) Process in CQI

Abstract

Get full access to this article

View all access options for this article.

References

Davis

Hess Fischl

Beck

, et al. 2022 National Standards for Diabetes Self-Management Education and Support. Diabetes Care. 2022;45(2):484-494. doi:10.2337/dc21-2396

Institute for Healthcare Improvement. Failure modes and effects analysis (FMEA) tool. Accessed May 25, 2025. https://www.ihi.org/resources/Pages/Tools/FailureModesandEffectsAnalysisTool.aspx

American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(suppl 1):S1-S352.

Aboumatar

Kinyua

Saliba

, et al. Using FMEA to enhance safety in clinical practice: a tool for proactive assessment. BMJ Open Qual. 2021;10(2):e001209.

Centers for Medicare & Medicaid Services. Guidance for failure mode and effects analysis (FMEA). 2020. Accessed July 21, 2025. https://www.cms.gov/medicare/provider-enrollment-and-certification/qapi/downloads/guidanceforfmea.pdf

Shepherd

Wiles

Brook

Using FMEA in nursing to reduce risks in medication titration. J Nurs Manag. 2023;31(1):12-18.

Gavin

Abaniel

Virdi

NS.

Therapeutic inertia and delays in insulin intensification in type 2 diabetes: a literature review. Diabetes Spectr. 2023;36(4):379-384. doi:10.2337/ds22-0084

Institute for Safe Medication Practices. Guidelines for Standard Order Sets. 2020.

Snyder

Mitchell

Chewning

Enhancing insulin safety: team-based insulin titration protocols. J Am Pharm Assoc. 2022;62(4):1192-1197.